Literature DB >> 23671749

Evaluation of cancer treatment in the abdomen: Trends and advances.

Silanath Peungjesada1, Hubert H Chuang, Srinivasa R Prasad, Haesun Choi, Evelyne M Loyer, Yulia Bronstein.   

Abstract

Response evaluation in Oncology has relied primarily on change in tumor size. Inconsistent results in the prediction of clinical outcome when size based criteria are used and the increasing role of targeted and loco-regional therapies have led to the development of new methods of response evaluation that are unrelated to change in tumor size. The goals of this review are to expose briefly the size based criteria and to present the non-size based approaches that are currently applicable in the clinical setting. Other paths that are still being explored are not discussed in details.

Entities:  

Keywords:  Abdomen; Cancer treatment; Evaluation

Year:  2013        PMID: 23671749      PMCID: PMC3650203          DOI: 10.4329/wjr.v5.i3.126

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  146 in total

Review 1.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Authors:  B D Cheson; S J Horning; B Coiffier; M A Shipp; R I Fisher; J M Connors; T A Lister; J Vose; A Grillo-López; A Hagenbeek; F Cabanillas; D Klippensten; W Hiddemann; R Castellino; N L Harris; J O Armitage; W Carter; R Hoppe; G P Canellos
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

2.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Authors:  R C Flanigan; S E Salmon; B A Blumenstein; S I Bearman; V Roy; P C McGrath; J R Caton; N Munshi; E D Crawford
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

Review 3.  Image-guided tumor ablation: standardization of terminology and reporting criteria.

Authors:  S Nahum Goldberg; Clement J Grassi; John F Cardella; J William Charboneau; Gerald D Dodd; Damian E Dupuy; Debra Gervais; Alice R Gillams; Robert A Kane; Fred T Lee; Tito Livraghi; John McGahan; David A Phillips; Hyunchul Rhim; Stuart G Silverman
Journal:  Radiology       Date:  2005-04-21       Impact factor: 11.105

4.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

Authors:  Scott Kopetz; George J Chang; Michael J Overman; Cathy Eng; Daniel J Sargent; David W Larson; Axel Grothey; Jean-Nicolas Vauthey; David M Nagorney; Robert R McWilliams
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

Review 5.  Diffusion-weighted MR imaging of the liver.

Authors:  Bachir Taouli; Dow-Mu Koh
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

6.  Response to treatment series: part 1 and introduction, measuring tumor response--challenges in the era of molecular medicine.

Authors:  Daniel C Sullivan; Constantine Gatsonis
Journal:  AJR Am J Roentgenol       Date:  2011-07       Impact factor: 3.959

7.  Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.

Authors:  Lorenza Rimassa; Armando Santoro
Journal:  Expert Rev Anticancer Ther       Date:  2009-06       Impact factor: 4.512

8.  Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?

Authors:  Alejandro Forner; Carmen Ayuso; María Varela; Jordi Rimola; Amelia J Hessheimer; Carlos Rodriguez de Lope; María Reig; Luís Bianchi; Josep M Llovet; Jordi Bruix
Journal:  Cancer       Date:  2009-02-01       Impact factor: 6.860

9.  Evaluation of sorafenib treatment in metastatic renal cell carcinoma with 2-fluoro-2-deoxyglucose positron emission tomography and computed tomography.

Authors:  David Lyrdal; Marianne Boijsen; Madis Suurküla; Sven Lundstam; Ulrika Stierner
Journal:  Nucl Med Commun       Date:  2009-07       Impact factor: 1.690

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  1 in total

1.  Oncological imaging of the abdomen and pelvis: Spectrum of trends and advances.

Authors:  Khaled M Elsayes
Journal:  World J Radiol       Date:  2013-03-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.